Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

AdvaMed communications program

This article was originally published in The Gray Sheet

Executive Summary

AdvaMed plans to launch a targeted communications program for device manufacturers in 2007, Exec-VP Blair Childs reported during the Merrill Lynch Med-Tech Fundamentals Conference Dec. 1 in New York City. "We need to do a much, much better job at communicating as an industry," Childs said. The program will teach manufacturers to communicate in a more consistent fashion to prevent the medical device industry from being viewed in a negative light following the increased use of direct-to-consumer advertising and unfavorable media attention on the implantable defibrillator recalls last summer...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT022963

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel